Niewczas, M. A., & Krolewski, A. S. (2017). Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40: 383–390. Diabetes Care.
Chicago-стиль цитированияNiewczas, Monika A., and Andrzej S. Krolewski. "Response to Comment On Niewczas Et Al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40: 383–390." Diabetes Care 2017.
MLA-цитированиеNiewczas, Monika A., and Andrzej S. Krolewski. "Response to Comment On Niewczas Et Al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40: 383–390." Diabetes Care 2017.